Wednesday, May 15, 2024 5:11:30 PM
Ten years ago -- 2014 -- PRs got people excited because ten years ago investors had these things to get excited about:
* FDA clearance was on the horizon.
* The O/S was only 5.3 billion.
* Nobody knew the Whelans and Staelin would convert and dump billions of shares.
* The company had patents.
* The company maintained a Pink Current status.
That's ALL gone now. Today, a PR about another FDA clearance or another OEM Partner or another generation of devices or re-certifying the CE Mark won't excite anyone. They've released PR's in the past year about veterinary breakthroughs and more studies and a potential lawsuit against Mundipharma, but investors are weary of the hype. News doesn't excite anyone anymore unless it's news about REVENUES.
And where will significant revenues come from? They're operating on a shoestring, cutting expenses everywhere, trying to generate sales without a Sales VP, spending as little as possible on sales and marketing. When they get a $100,000 order it takes them two months to package and ship it.
Ilfeld's opioid study results might bump the PPS a tic or two. Woo hoo. We might see .0003. Be still my beating heart.
FEATURED DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio • Jun 7, 2024 10:15 AM
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM